Clinical Trials on Benign Ovarian Tumor in Japan
Total 447 results
-
Eli Lilly and CompanyActive, not recruitingRelapsed Solid Tumor | Refractory Solid TumorUnited States, France, Australia, Belgium, Germany, Japan, Spain, Italy
-
Translational Research Center for Medical Innovation...Department of Nuerosurgery, Osaka Medical CollegeCompletedBrain and Central Nervous System TumorsJapan
-
Eisai Co., Ltd.Completed
-
AstraZenecaActive, not recruiting
-
TakedaCompletedAdvanced Solid TumorsJapan
-
Novartis PharmaceuticalsCompleted
-
Daiichi Sankyo Co., Ltd.Completed
-
Astellas Pharma IncCompletedAdvanced Solid TumorsJapan
-
SanofiCompleted
-
SanofiCompletedAdvance Solid TumorsJapan
-
BayerRecruitingAdvanced or Recurrent Solid Tumor Harboring an NTRK Gene FusionJapan
-
AstraZenecaTerminatedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
Novartis PharmaceuticalsTerminated
-
Taiho Pharmaceutical Co., Ltd.CompletedAdvanced Solid TumorsJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Guangzhou Virotech Pharmaceutical Co., Ltd.Recruiting
-
GlaxoSmithKlineCompleted
-
Chugai PharmaceuticalRecruitingSolid TumorUnited States, Japan
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
AO Innovation Translation CenterAO Foundation, AO SpineRecruitingMetastatic Spine TumorUnited States, Canada, Hungary, Australia, Germany, Italy, Japan, Netherlands, Singapore, Switzerland
-
Novartis PharmaceuticalsCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Keio UniversityMerck Sharp & Dohme LLC; Ohara Pharmaceutical Co., Ltd.Recruiting
-
Eli Lilly and CompanyCompletedBenign Prostatic HyperplasiaKorea, Republic of, Japan
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsJapan
-
Novartis PharmaceuticalsCompleted
-
Wakayama Medical UniversityOsaka University; Kyoto Prefectural University of Medicine; Nara Medical University and other collaboratorsCompletedPancreatic Cancer | Chronic Pancreatitis | Pancreatic Cystic Lesions | Pancreatic Neuroendocrine Tumors | Pancreatic PseudocystsJapan
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
Bristol-Myers SquibbCompleted
-
ExelixisCompletedCancer | NSCLC | Solid TumorsJapan
-
Eli Lilly and CompanyTerminatedSolid TumorBelgium, United States, Japan
-
Eli Lilly and CompanyTerminatedAdvanced Solid TumorUnited States, Japan
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous... and other conditionsUnited States, Korea, Republic of, Canada, Japan
-
Kyowa Kirin, Inc.RecruitingGastric Adenocarcinoma | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
TakedaActive, not recruiting
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsTerminatedMelanoma | Ovarian Neoplasms | Non-Small-Cell Lung Carcinoma | Other Solid TumorsSpain, Germany, Singapore, Switzerland, Japan, United States
-
Merck KGaA, Darmstadt, GermanyThreshold PharmaceuticalsCompletedPancreatic Cancer | Solid TumorJapan
-
Chugai PharmaceuticalRecruitingSolid TumorUnited States, Japan
-
AbbVieCompletedAdvanced Solid Tumors CancerJapan
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive Neuroendocrine TumorJapan
-
AstraZenecaCompleted
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
Cancer Intelligence Care Systems, Inc.Stella Pharma CorporationCompletedAngiosarcoma | Malignant MelanomaJapan
-
Ludwig Institute for Cancer ResearchMie UniversityCompletedStomach Cancer | Breast Cancer | Esophageal Cancer | Ovarian Cancer | Lung CancerJapan